These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27864873)

  • 21. Hereditary hemorrhagic telangiectasia: to transplant or not to transplant?
    Dupuis-Girod S; Buscarini E
    Liver Int; 2016 Dec; 36(12):1741-1744. PubMed ID: 27864870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient.
    Ha M; Kim YJ; Kwon KA; Hahm KB; Kim MJ; Kim DK; Lee YJ; Oh SP
    World J Gastroenterol; 2012 Apr; 18(15):1840-4. PubMed ID: 22553411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers.
    Al-Samkari H; Albitar HA; Olitsky SE; Clancy MS; Iyer VN
    Orphanet J Rare Dis; 2019 Nov; 14(1):256. PubMed ID: 31727111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary hypertension and hepatic encephalopathy: lethal complications of Rendu-Osler-Weber disease.
    Ford TJ; Fong MW; Cheah BC; Alexopolous C
    J R Coll Physicians Edinb; 2014; 44(2):126-9. PubMed ID: 24999773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Osler-Weber-Rendu disease presenting with hepatocellular carcinoma: radiologic and genetic findings.
    Lee JH; Lee YS; Kim PN; Lee BH; Kim GW; Yoo HW; Heo NY; Lim YS; Lee HC; Chung YH; Suh DJ
    Korean J Hepatol; 2011 Dec; 17(4):313-8. PubMed ID: 22310796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.
    Singh S; Swanson KL; Hathcock MA; Kremers WK; Pallanch JF; Krowka MJ; Kamath PS
    J Hepatol; 2014 Jul; 61(1):124-31. PubMed ID: 24607625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver Transplantation Trends and Outcomes for Hereditary Hemorrhagic Telangiectasia in the United States.
    Iyer VN; Saberi B; Heimbach JK; Larson JJ; Raghavaiah S; Ditah I; Swanson K; Kamath PS; Watt KD; Taner T; Krowka MJ; Leise MD
    Transplantation; 2019 Jul; 103(7):1418-1424. PubMed ID: 30335701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bevacizumab as a treatment for hereditary hemorrhagic telangiectasia in children: a case report.
    Ospina FE; Echeverri A; Posso-Osorio I; Jaimes L; Gutierrez J; Tobón GJ
    Colomb Med (Cali); 2017 Jun; 48(2):88-93. PubMed ID: 29021642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bevacizumab: an option for refractory epistaxis in hereditary haemorrhagic telangiectasia.
    Amann A; Steiner N; Gunsilius E
    Wien Klin Wochenschr; 2015 Aug; 127(15-16):631-4. PubMed ID: 25986996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia.
    Azzopardi N; Dupuis-Girod S; Ternant D; Fargeton AE; Ginon I; Faure F; Decullier E; Roux A; Carette MF; Gilbert-Dussardier B; Hatron PY; Lacombe P; Leguy-Seguin V; Rivière S; Corre R; Bailly S; Paintaud G
    MAbs; 2015; 7(3):630-7. PubMed ID: 25751241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iron deficiency anemia related to hereditary hemorrhagic telangiectasia: response to treatment with bevacizumab.
    Fleagle JM; Bobba RK; Kardinal CG; Freter CE
    Am J Med Sci; 2012 Mar; 343(3):249-51. PubMed ID: 22227516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of patients with hereditary hemorrhagic telangiectasia and severe hepatic involvement after orthotopic liver transplantation: a single-center study.
    Dupuis-Girod S; Chesnais AL; Ginon I; Dumortier J; Saurin JC; Finet G; Decullier E; Marion D; Plauchu H; Boillot O
    Liver Transpl; 2010 Mar; 16(3):340-7. PubMed ID: 20209594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bevacizumab for treating Hereditary Hemorrhagic Telangiectasia patients with severe hepatic involvement or refractory anemia.
    Vázquez C; Gonzalez ML; Ferraris A; Bandi JC; Serra MM
    PLoS One; 2020; 15(2):e0228486. PubMed ID: 32032395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver disease in patients with hereditary hemorrhagic telangiectasia.
    Garcia-Tsao G; Korzenik JR; Young L; Henderson KJ; Jain D; Byrd B; Pollak JS; White RI
    N Engl J Med; 2000 Sep; 343(13):931-6. PubMed ID: 11006369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravenous Bevacizumab for Refractory Hereditary Hemorrhagic Telangiectasia-Related Epistaxis and Gastrointestinal Bleeding.
    Iyer VN; Apala DR; Pannu BS; Kotecha A; Brinjikji W; Leise MD; Kamath PS; Misra S; Begna KH; Cartin-Ceba R; DuBrock HM; Krowka MJ; O'Brien EK; Pruthi RK; Schroeder DR; Swanson KL
    Mayo Clin Proc; 2018 Feb; 93(2):155-166. PubMed ID: 29395350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical management of haemorrhagic hereditary telangiectasia in adult patients.
    Riera-Mestre A; Ribas J; Castellote J
    Med Clin (Barc); 2019 Apr; 152(7):274-280. PubMed ID: 30502301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Bevacizumab in Hereditary Hemorrhagic Telangiectasia-Related Bleeding and High-Output Cardiac Failure: Significant Inter-Individual Variability in the Need for Maintenance Therapy.
    Albitar HAH; Almodallal Y; Gallo De Moraes A; O'Brien E; Choby GW; Pruthi RK; Stokken JK; Kamath PS; Cajigas HR; DuBrock HM; Krowka MJ; Iyer VN
    Mayo Clin Proc; 2020 Aug; 95(8):1604-1612. PubMed ID: 32753135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
    Dupuis-Girod S; Shovlin CL; Kjeldsen AD; Mager HJ; Sabba C; Droege F; Fargeton AE; Fialla AD; Gandolfi S; Hermann R; Lenato GM; Manfredi G; Post MC; Rennie C; Suppressa P; Sure U; ; Buscarini E
    Eur J Med Genet; 2022 Oct; 65(10):104575. PubMed ID: 35940549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward.
    Krowka MJ; Wiesner RH; Heimbach JK
    J Hepatol; 2013 Aug; 59(2):367-74. PubMed ID: 23557870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatocellular Carcinoma in a Patient with Hereditary Hemorrhagic Telangiectasia.
    Morii K; Uematsu R; Yamamoto T; Nakamura S; Okushin H; Nishiwaki N; Watanabe T; Kai K; Sato S
    Intern Med; 2018 Dec; 57(24):3545-3549. PubMed ID: 30146556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.